A Study of Rituximab Versus Iodine I 131 Tositumomab Therapy for Patients With Non-Hodgkin’s Lymphoma
Condition(s):Non-Hodgkin’s LymphomaLast Updated:November 9, 2005Unknown status
Hide Studies Not Open or Pending
Condition(s):Non-Hodgkin’s LymphomaLast Updated:November 9, 2005Unknown status
Condition(s):Non-Small Cell Lung CancerLast Updated:December 6, 2006Unknown status
Condition(s):Non-Hodgkin’s LymphomaLast Updated:June 24, 2005Unknown status
Condition(s):Mantle Cell LymphomaLast Updated:June 24, 2005Completed
Condition(s):Non-Hodgkin’s LymphomaLast Updated:June 24, 2005Unknown status
Condition(s):Non-Hodgkin’s LymphomaLast Updated:June 24, 2005Unknown status
Condition(s):Non-Hodgkin’s LymphomaLast Updated:June 24, 2005Unknown status
Condition(s):Chronic Lymphocytic LeukemiaLast Updated:June 24, 2005Unknown status
Condition(s):Tuberculosis (TB)Last Updated:August 8, 2008Completed
Condition(s):LymphomaLast Updated:March 30, 2017Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.